Back
Biomarin Pharmaceutical Stock Price Chart
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
BMRN
Biomarin Pharmaceutical
Last Price:
68.71
Seasonality Move:
11.99%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.49 | Sell |
| 20-day SMA: | 72.07 | Sell |
| 50-day SMA: | 81.8 | Sell |
| 200-day SMA: | 85.25 | Sell |
| 8-day EMA: | 69.5 | Sell |
| 20-day EMA: | 72.79 | Sell |
| 50-day EMA: | 78.33 | Sell |
| 200-day EMA: | 84.01 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.98 | Sell |
| Relative Strength Index (14 RSI): | 28.72 | Sell |
| Chaikin Money Flow: | 505933 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.49 - 82.09) | Sell |
| Bollinger Bands (100): | (74.92 - 88.58) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 68.69 while BMRN 8-day simple moving average is 69.49, which is a Sell signal.
- The stock price of BMRN is 68.69 while Biomarin Pharmaceutical 20-day SMA is 72.07, which makes it a Sell.
- Biomarin Pharmaceutical 50-day simple moving average is 81.80 while BMRN share price is 68.69, making it a Sell technically.
- BMRN stock price is 68.69 and Biomarin Pharmaceutical 200-day simple moving average is 85.25, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Sell
35
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Sell
The current Biomarin Pharmaceutical [BMRN] share price is $68.69. The Score for BMRN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
13.08B
Price in USD:
68.69
Share Volume:
1.4M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.56
52-Week Low:
67.75
Sell
35
Biomarin Pharmaceutical (BMRN)
is a Sell
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?
The Biomarin Pharmaceutical stock price is 68.69 USD today. -
Will BMRN stock go up or go down?
Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Biomarin Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 68.69 while BMRN 8-day exponential moving average is 69.50, which is a Sell signal.
- The stock price of BMRN is 68.69 while Biomarin Pharmaceutical 20-day EMA is 72.79, which makes it a Sell.
- Biomarin Pharmaceutical 50-day exponential moving average is 78.33 while BMRN share price is 68.69, making it a Sell technically.
- BMRN stock price is 68.69 and Biomarin Pharmaceutical 200-day simple moving average is 84.01, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
- BMRN Moving Average Covergence Divergence (MACD) indicator is -3.98, suggesting Biomarin Pharmaceutical is a Sell
- Biomarin Pharmaceutical Relative Strength Index (RSI) is 28.72, which suggest Biomarin Pharmaceutical is oversold
- The Bollinger Bands (25) for Biomarin Pharmaceutical is (67.49 - 82.09), which suggest Biomarin Pharmaceutical is a Sell
- The Bollinger Bands (100) for Biomarin Pharmaceutical is (74.92 - 88.58), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.